Adrenal Cushing’s Syndrome Treated With Preoperative Osilodrostat and Adrenalectomy
Background/Objective: Reducing severity of Cushing’s syndrome caused by an adrenal adenoma (adrenal Cushing’s syndrome [ACS]) might decrease morbidity and mortality risk in adrenalectomy. We used off-label osilodrostat, approved in the United States for pituitary Cushing’s disease, to reduce cortiso...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | AACE Clinical Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060522000657 |